Biochem/physiol Actions
Olanzapine is a 5-HT2 serotonin and D1/D2 dopamine receptor antagonist.
Features and Benefits
This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 51141704
- Condition:
- New
- HazmatClass:
- No
- MPN:
- O1141-50MG
- CAS:
- 132539-06-1
akash.verma@cenmed.com
(732) 447-1115





